- Investing Ideas
- /
- Global Healthcare Potential Opportunities
Global Healthcare Potential Opportunities
UPDATED Jun 27, 2022
Companies that are potentially undervalued based on future cash flows and market ratios.
333 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| KOSSANKossan Rubber Industries Bhd | RM1.30 | -7.1% | -61.2% | RM3.3b | RM1.96 | PS1.7x | E-9.8% | 36.9% | ||
| 569Vicplas International | S$0.20 | -1.0% | -15.7% | S$101.2m | n/a | PS9.7x | E10.5% | 2.3% | ||
| MLSBTScientific Brain Training | €5.45 | 0% | -0.9% | €10.8m | n/a | PB1.8x | n/a | n/a | ||
| ILXIlex Medical | ₪125.80 | 4.4% | 18.9% | ₪1.4b | n/a | PS7x | n/a | 4.2% | ||
| MEDICMedicon Hellas | €2.90 | -1.4% | 27.2% | €12.8m | n/a | PS4.2x | n/a | 0% | ||
| GEMAInternational Medical Center of Biomaterials Processing and Cryostorage | ₽682.50 | -0.6% | 0% | ₽1.0b | n/a | PS7.6x | n/a | 12.7% | ||
| CONTXContextVision | kr8.14 | -1.3% | -55.0% | kr629.8m | kr12.00 | PS18.8x | E15.1% | n/a | ||
| OSSRÖssur hf | kr.30.30 | 3.4% | -35.3% | kr.12.8b | kr.45.45 | PS29.5x | E15.5% | 0% | ||
| RENXRenalytix | UK£1.68 | 6.3% | -85.0% | UK£125.2m | UK£3.97 | PS63.7x | E49.5% | n/a | ||
| LAS CONDESClÃnica Las Condes | CL$13,847.00 | 0% | -49.6% | CL$116.0b | n/a | PS8.7x | n/a | 0% | ||
| BLMHBloom Health Partners | CA$0.20 | -7.0% | -51.2% | CA$7.9m | n/a | PS4.2x | n/a | n/a | ||
| ZIMVZimVie | US$17.06 | -5.7% | n/a | US$444.9m | US$26.00 | PS-3.7x | E123.5% | n/a | ||
| BMRABiomerica | US$3.00 | 2.0% | -25.9% | US$38.6m | n/a | PS2.6x | n/a | n/a | ||
| VIPVIP Gloves | AU$0.011 | -15.4% | -76.1% | AU$8.7m | n/a | PS-3.7x | n/a | 20.9% | ||
| 9265Yamashita Health Care HoldingsInc | JPÂ¥1,890.00 | 3.2% | -3.0% | JPÂ¥4.7b | n/a | PS6.2x | n/a | 3.3% | ||
| 2044Meinian Onehealth Healthcare Holdings | CNÂ¥5.33 | -0.6% | -42.9% | CNÂ¥20.3b | CNÂ¥5.60 | PS357.5x | E47.4% | 0% | ||
| 3733Software Service | JPÂ¥6,460.00 | 7.1% | -37.9% | JPÂ¥33.9b | n/a | PS10.3x | n/a | 1.5% | ||
| 4595Mizuho MedyLtd | JPÂ¥2,510.00 | 3.6% | 5.2% | JPÂ¥24.4b | JPÂ¥2,500.00 | PS3.9x | n/a | n/a | ||
| 6034MRT | JPÂ¥1,278.00 | 0.9% | -14.2% | JPÂ¥6.9b | n/a | PS5.1x | n/a | n/a | ||
| 1406Clarity Medical Group Holding | HK$1.16 | -0.9% | n/a | HK$625.5m | n/a | PS16.9x | n/a | n/a | ||
| 1419Human Health Holdings | HK$1.61 | -0.6% | 67.7% | HK$611.1m | n/a | PS2.8x | n/a | 7.5% | ||
| 4735AViTA | NT$34.80 | -2.8% | -53.8% | NT$1.3b | n/a | PS7.9x | n/a | 17.8% | ||
| 4171GeneReach Biotechnology | NT$95.00 | -0.6% | -25.3% | NT$4.0b | n/a | PS10.4x | n/a | 3.6% | ||
| A122310Genoray | â‚©8,450.00 | 0.4% | -19.9% | â‚©117.5b | n/a | PS8.1x | n/a | 2.0% |